Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food ... Read More
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food ... Read More
The Association of Black Cardiologists (ABC), a national 501c3 nonprofit ... Read More